Showing results (141-150 of 200) with videos related to

Sort By:
Pageof 20
The Journal of Clinical Investigation|April 18, 2018
β-Catenin-mediated immune evasion pathway frequently operates in primary cutaneous melanomasJérémie Nsengimana, Jon Laye, Anastasia Filia, et al.
Health Technology Assessment (Winchester, England)|June 29, 2026
Effectiveness of non-pharmacological interventions for fatigue in adults with long-term conditions: a synopsis of the EIFFEL mixed-methods evidence synthesisJoanna Leaviss, Andrew Booth, David Coyle, et al.
BMJ Medicine|March 19, 2026
Effectiveness of non-pharmacological interventions for fatigue in long term conditions: systematic review and network meta-analysisJoanna Leaviss, Jessica E Forsyth, Andrew Booth, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 2012
Perceptions of genetic research and testing among members of families with an increased risk of malignant melanomaRichard Bränström, Nadine A Kasparian, Paul Affleck, et al.
Cancer Discovery|October 19, 2022
Identifying the Transcriptional Drivers of Metastasis Embedded within Localized MelanomaShruthy Suresh, Roy Rabbie, Manik Garg, et al.
Neoplasia (New York, N.Y.)|April 12, 2021
Transcriptional signatures underlying dynamic phenotypic switching and novel disease biomarkers in a linear cellular model of melanoma progressionDiogo de Oliveira Pessoa, Flávia Eichemberger Rius, Debora D'Angelo Papaiz, et al.
International Journal of Molecular Sciences|October 13, 2021
Road to Metastasis: The TWEAK Pathway as a Discriminant between Metastasizing and Non-Metastasizing Thick MelanomasCanan Güvenç, Asier Antoranz, Anna Szumera-Ciećkiewicz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2019
Transcriptomic Analysis Reveals Prognostic Molecular Signatures of Stage I MelanomaRohit Thakur, Jonathan P Laye, Martin Lauss, et al.
Pigment Cell & Melanoma Research|November 20, 2015
The CDKN2A/p16(INK) (4a) 5'UTR sequence and translational regulation: impact of novel variants predisposing to melanomaVirginia Andreotti, Alessandra Bisio, Brigitte Bressac-de Paillerets, et al.
Cancer Management and Research|May 26, 2018
MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP projectElena Tagliabue, Sara Gandini, Rino Bellocco, et al.
Pageof 20